Results 41 to 50 of about 1,635 (133)

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis). [PDF]

Front Immunol, 2023
Gargiulo L, Ibba L, Malagoli P, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Mercuri SR, Travaglini M, Costanzo A, Narcisi A.   +20 more
europepmc   +1 more source

Evaluation of sleep quality and pruritus severity in psoriatic patients and their impact on quality of life: a cross section correlational study. [PDF]

Sci Rep, 2023
Zaky MS, Elgamal EEA, Abd Al Maksoud AA, Mohamed DH, Elsaie ML.   +4 more
europepmc   +1 more source

Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits. [PDF]

Int J Mol Sci, 2021
Mercurio L, Morelli M, Scarponi C, Scaglione GL, Pallotta S, Avitabile D, Albanesi C, Madonna S.   +7 more
europepmc   +1 more source

Effect of multipotent mesenchymal stromal cells secretome on imiquimod-induced psoriasis in rats [PDF]

, 2019
Multipotent mesenchymal stromal cells secretome contains a range of anti-inflammatory factors and can be used for the treatment of ...
Bondarev, V. P., Burda, Yu. E., Danilenko, L. M., Mycic, A. V., Nadezhdin, S. V., Nadezhdina, N. A., Peresypkina, A. A., Pokrovskiy, M. V.   +7 more
core  

Inflamació i macròfags [PDF]

, 2014
Els macròfags tenen un paper clau en la inflamació. Durant l'inici del procés inflamatori aquestes cèl·lules s'activen i mostren una potent funció fagocítica i microbicida que pot tenir efectes destructius en els teixits on actua.
Celada Cotarelo, Antonio, Lloberas Cavero, Jorge   +1 more
core  

Jornada d’Estudi: La violència en la parella i la família [PDF]

, 2013
Psicoanalista SEP ...
Romagosa, Anna
core  

Costo per responder di risankizumab e secukinumab nel trattamento della psoriasi a placche da moderata a grave in Italia. [PDF]

Glob Reg Health Technol Assess, 2021
Gisondi P, Loconsole F, Raimondo P, Ravasio R.   +3 more
europepmc   +1 more source

THE HISTOPATHOLOGY OF PSORIASIS

Reumatismo, 2011
Psoriasis is a common, chronic, relapsing, papulo-squamous dermatitis, with overlying silvery scales. The scalp, sacral region, and extensor surfaces of extremity are commonly involved, even if flexural and intertriginous areas may be affected in the so-called "inverse psoriasis". Involvement of nails is frequent.
DE ROSA, GAETANO, Mignogna C.
openaire   +5 more sources

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis). [PDF]

Front Med (Lausanne), 2023
Gargiulo L, Ibba L, Malagoli P, Amoruso F, Argenziano G, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Fabbrocini G, Franchi C, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Sampogna F, Travaglini M, Costanzo A, Narcisi A.   +24 more
europepmc   +1 more source

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. [PDF]

Patient Prefer Adherence, 2021
Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L.   +22 more
europepmc   +1 more source